Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Apr 2022 07:00 AM
RNS
Holding(s) in Company
01 Apr 2022 07:02 AM
RNS
Total Voting Rights
28 Mar 2022 01:19 PM
RNS
Grant of Options and PDMR Dealing
28 Mar 2022 07:00 AM
RNS
Grant of Options and PDMR Dealing
23 Mar 2022 07:00 AM
RNS
Fourth Quarter and Full Year Financial Results
10 Mar 2022 07:00 AM
RNS
MaxCyte, Names Cenk Sumen Chief Scientific Officer
08 Mar 2022 02:29 PM
RNS
Holding(s) in Company
03 Mar 2022 09:45 AM
RNS
Holding(s) in Company
01 Mar 2022 07:00 AM
RNS
Block Listing Return
24 Feb 2022 01:00 PM
RNS
Notice of Results
22 Feb 2022 03:56 PM
RNS
Holding(s) in Company
21 Feb 2022 07:00 AM
RNS
Consolidation of Trading Lines
14 Feb 2022 01:00 PM
RNS
Upcoming Investor Conferences
14 Feb 2022 07:00 AM
RNS
Inducement Grants Under Nasdaq Listing Rule
01 Feb 2022 07:00 AM
RNS
License with Intima Bioscience
24 Jan 2022 07:30 AM
RNS
Preliminary Unaudited Q4 & FY 2021 Revenue Results
29 Dec 2021 03:30 PM
RNS
Holdings in Company
01 Dec 2021 05:00 PM
RNS
Total Voting Rights
23 Nov 2021 07:32 AM
RNS
Purchase of Common Stock
17 Nov 2021 05:36 PM
RNS
Exercise of options and PDMR Dealing
11 Nov 2021 07:00 AM
RNS
MaxCyte Reports Third Quarter Financial Results
03 Nov 2021 01:00 PM
RNS
Appointment of Chairman of the Board
29 Oct 2021 05:01 PM
RNS
Result of AGM
28 Oct 2021 03:00 PM
RNS
License with Nkarta, Inc.
26 Oct 2021 07:00 AM
RNS
Notice of Results
06 Oct 2021 07:00 AM
RNS
Holdings in Company
01 Oct 2021 03:49 PM
RNS
Notice of AGM and Change of Director
01 Oct 2021 12:36 PM
RNS
Total Voting Rights
17 Sep 2021 02:35 PM
RNS
MaxCyte Set to Join Russell 2000® Index
14 Sep 2021 07:00 AM
RNS
Filing of Form 10-Q
14 Sep 2021 07:00 AM
RNS
Half-year Report
06 Sep 2021 05:21 PM
RNS
Issue of Equity and Total Voting Rights
02 Sep 2021 02:26 PM
RNS
Notice of Results
10 Aug 2021 07:00 AM
RNS
Grant of Options
09 Aug 2021 07:00 AM
RNS
License with Sana Biotechnology
05 Aug 2021 04:05 PM
RNS
Amendments to Bylaws
03 Aug 2021 03:51 PM
RNS
Closing of Offering
02 Aug 2021 07:00 AM
RNS
Full Exercise of Over-Allotment Option
30 Jul 2021 04:43 PM
RNS
Second Price Monitoring Extn
30 Jul 2021 04:36 PM
RNS
Price Monitoring Extension
30 Jul 2021 07:00 AM
RNS
Pricing of Offering and Approval to List on Nasdaq
26 Jul 2021 11:14 AM
RNS
Launch of Offering and Application to List
19 Jul 2021 12:30 PM
RNS
Termination of DI facility and transition to CDI
12 Jul 2021 07:00 AM
RNS
S-1 Financial information & Directorate Change
12 Jul 2021 07:00 AM
RNS
Public Filing of Registration Statement with SEC
06 Jul 2021 05:36 PM
RNS
Result of Special Meeting
16 Jun 2021 07:01 AM
RNS
Publication of Annual Report and Accounts
16 Jun 2021 07:00 AM
RNS
Stockholder Circular and Notice of Special Meeting
15 Jun 2021 07:00 AM
RNS
Maxcyte Appoints Two New Non-Executive Directors
02 Jun 2021 09:18 AM
RNS
Total Voting Rights
UK 100